Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.
about
Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.Pathways driving the endocytosis of mutant and wild-type EGFR in cancer.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells.Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational Modeling.
P2860
Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@ast
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@en
type
label
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@ast
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@en
prefLabel
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@ast
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@en
P2093
P2860
P356
P1433
P1476
Epidermal growth factor recept ...... alters gefitinib sensitivity.
@en
P2093
Hiroshi Tanaka
Mariko Okada-Hatakeyama
Ryoko Ushikoshi-Nakayama
Shih-Feng Tsai
Takashi Naka
Takashi Nakakuki
Takeshi Nagashima
Yoshimi Naruo
Yuko Saeki
P2860
P2888
P356
10.1186/1752-0509-5-29
P577
2011-02-18T00:00:00Z
P5875
P6179
1021292813